Financial PerformanceUS sales of TMDX are estimated to be $128.2M, which is up approximately 40% year over year.
Market PositionTransMedics' OCS platform and full-service logistics have fundamentally reshaped liver transplantation at our KOL's center and across the U.S. by unlocking widespread use of DCD livers, facilitating growth in transplant volumes, and improving clinical outcomes and patient experiences.
Revenue GuidanceTMDX provided 2025 revenue guidance above consensus.